Both in Pharmaceuticals
Xenetic Biosciences vs Dermata Therapeutics
Over the past year XBIO returned −30.2% and DRMA returned −78.3%; their daily moves had a correlation of 0.07.
XBIO −30.2% DRMA −78.3%Growth of $1, one year, split-adjusted
| Metric | XBIO | DRMA |
|---|---|---|
| Price | $2.26 | $1.13 |
| Market cap | $5.3M | $5.6M |
| Today | −3.00% | +0.89% |
| 1 month | −43.2% | −15.7% |
| 6 months | −15.4% | −0.9% |
| Year to date | +4.1% | −51.3% |
| 1 year | −27.1% | −78.2% |
| Revenue growth (YoY) | +12.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | — |
| Net cash | $6.5M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 157.1% | 85.6% |
| Short % of float | 1.2% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).